Compare fund portfolios

See how two funds' portfolios overlap. Enter two tickers:

vs

LABU vs PROFUND VP BIOTECHNOLOGY

Shared holdings
145
LABU covered by B
78.45%
B covered by LABU
78.45%

Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.

LABU (April 30, 2026)

SecurityWeight
DREYFUS GOVT CASH MGMT FUND7.43%
US ULTRA BOND CBT Sep257.26%
GOLDMAN FINL SQ TRSRY INST 5066.27%
GOLDMAN SACHS FIN GOV 465 INSTITUT1.71%
APELLIS PHARMACEUTICALS INC1.44%
REVOLUTION MEDICINES INC1.27%
TRAVERE THERAPEUTICS INC1.25%
ARROWHEAD PHARMACEUTICALS INC1.11%
TWIST BIOSCIENCE CORP1.10%
SUMMIT THERAPEUTICS INC1.09%
ALKERMES PLC1.07%
TG THERAPEUTICS INC1.06%
MADRIGAL PHARMACEUTICALS INC1.06%
BEAM THERAPEUTICS INC1.02%
APOGEE THERAPEUTICS INC0.98%
SCHOLAR ROCK HOLDING CORP0.95%
PRAXIS PRECISION MEDICINES INC0.95%
EXELIXIS INC0.94%
MIRUM PHARMACEUTICALS INC0.93%
UNITED THERAPEUTICS CORP DEL0.92%
NATERA INC0.92%
CELCUITY INC0.92%
CRISPR Therapeutics A.G. Series A0.92%
KRYSTAL BIOTECH INC0.91%
PROTAGONIST THERAPEUTICS INC0.90%
NEUROCRINE BIOSCIENCES INC0.89%
INCYTE CORP0.89%
CG ONCOLOGY INC0.89%
CYTOKINETICS INC0.89%
NUVALENT INC-A0.88%
IONIS PHARMACEUTICALS INC0.88%
BRIDGEBIO PHARMA INC0.88%
VAXCYTE INC0.88%
KYMERA THERAPEUTICS INC0.88%
BIOGEN INC0.87%
COGENT BIOSCIENCES INC0.87%
PTC THERAPEUTICS INC0.87%
INSMED INC0.86%
ALNYLAM PHARMACEUTICALS INC0.85%
ROIVANT SCIENCES0.85%
HALOZYME THERAPEUTICS INC0.84%
ARCUTIS BIOTHERAPEUTICS INC0.83%
SPYRE THERAPEUTICS INC0.83%
SOLENO THERAPEUTICS INC0.82%
ABBVIE INC0.82%
AMGEN INC0.81%
REGENERON PHARMACEUTICALS INC0.80%
ULTRAGENYX PHARMA INC0.80%
ACADIA PHARMACEUTICALS INC0.80%
RHYTHM PHARMACEUTICALS INC0.80%

PROFUND VP BIOTECHNOLOGY (March 31, 2026)

SecurityWeight
Invesco Government & Agency Portfolio2.34%
US ULTRA BOND CBT Sep252.34%
APELLIS PHARMACEUTICALS INC1.75%
ALKERMES PLC1.39%
MADRIGAL PHARMACEUTICALS INC1.32%
TG THERAPEUTICS INC1.29%
INSMED INC1.28%
SCHOLAR ROCK HOLDING CORP1.24%
APOGEE THERAPEUTICS INC1.23%
PROTAGONIST THERAPEUTICS INC1.19%
SUMMIT THERAPEUTICS INC1.18%
UNITED THERAPEUTICS CORP DEL1.18%
PRAXIS PRECISION MEDICINES INC1.18%
ARROWHEAD PHARMACEUTICALS INC1.17%
COGENT BIOSCIENCES INC1.16%
BRIDGEBIO PHARMA INC1.13%
PTC THERAPEUTICS INC1.13%
CYTOKINETICS INC1.13%
ALNYLAM PHARMACEUTICALS INC1.12%
EXELIXIS INC1.12%
NUVALENT INC-A1.11%
KYMERA THERAPEUTICS INC1.11%
CG ONCOLOGY INC1.11%
NATERA INC1.11%
NEUROCRINE BIOSCIENCES INC1.11%
TWIST BIOSCIENCE CORP1.10%
KRYSTAL BIOTECH INC1.10%
VAXCYTE INC1.10%
MIRUM PHARMACEUTICALS INC1.10%
AMICUS THERAPEUTICS INC1.09%
TRAVERE THERAPEUTICS INC1.09%
IONIS PHARMACEUTICALS INC1.09%
ARCELLX INC1.09%
REGENERON PHARMACEUTICALS INC1.08%
INCYTE CORP1.08%
CELCUITY INC1.07%
REVOLUTION MEDICINES INC1.06%
HALOZYME THERAPEUTICS INC1.06%
RHYTHM PHARMACEUTICALS INC1.05%
BIOGEN INC1.05%
ARCUTIS BIOTHERAPEUTICS INC1.04%
ABBVIE INC1.04%
GILEAD SCIENCES INC1.04%
CRISPR Therapeutics A.G. Series A1.04%
BIOMARIN PHARMACEUTICAL INC1.02%
ROIVANT SCIENCES1.02%
AMGEN INC1.01%
IMMUNITYBIO INC1.01%
BEAM THERAPEUTICS INC0.99%
VIKING THERAPEUTICS INC0.99%

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.